$USD
$USD
home / United States / Viracta Therapeutics
Viracta Therapeutics logo

Viracta Therapeutics Market Cap

$6.48 M
-0.14 M
NASDAQ:VIRX · January 22, 2025
Share price
$0.16
Enterprise Value
$0.49 M
Change (1-Year)
-65.3%
Global Rank
#8983
Country Rank
#3535
Regions
USA
Market cap

As of January 22, 2025, Viracta Therapeutics (VIRX) has a market cap of $6.482 million USD. According to our data, Viracta Therapeutics is ranked No.8983 in global market value.

Sector Rank:
VIRX Market Capitalization Growth
30D Growth:
-32.0%
1 Years Growth:
-65.3%
3 Years Growth:
-93.8%
5 Years Growth:
-99.1%
10 Years Growth:
-100.0%
15 Years Growth:
-100.0%
20 Years Growth:
-100.0%
Total Growth:
-99%

Viracta Therapeutics Market Cap Chart

1M
3M
6M
YTD
1Y
3Y
5Y
10Y
15Y
20Y
MAX

Viracta Therapeutics Market Cap CAGR Chart

Viracta Therapeutics Market Cap History 2005 - 2025

Year Market Cap %Change
Jan 22, 2025 $6.48 M
1.94%
Dec 31, 2024 $6.36 M
-71.93%
Dec 29, 2023 $22.65 M
-60.96%
Dec 30, 2022 $58.03 M
-60.00%
Dec 31, 2021 $0.15 B
-47.73%
Dec 31, 2020 $0.28 B
-41.47%
Dec 31, 2019 $0.47 B
-19.05%
Dec 31, 2018 $0.59 B
-88.62%
Dec 29, 2017 $5.15 B
1.93%
Dec 30, 2016 $5.05 B
-32.96%
Dec 31, 2015 $7.53 B
-64.71%
Dec 31, 2014 $21.34 B
-46.20%
Dec 31, 2013 $39.66 B
12.86%
Dec 31, 2012 $35.14 B
258.97%
Dec 30, 2011 $9.79 B
-62.50%
Dec 31, 2010 $26.11 B
-51.40%
Dec 31, 2009 $53.72 B
234.37%
Dec 31, 2008 $16.07 B
-83.92%
Dec 31, 2007 $99.90 B
-55.97%
Dec 29, 2006 $226.92 B
-9.24%
Dec 30, 2005 $250.01 B
100%

Similar Companies to Viracta Therapeutics

Name Market Cap Market cap difference Regions
Kura Oncology Logo
Kura Oncology
KURA
$0.61 B
0.000 M
USA icon
USA
Syndax Pharmaceuticals Logo
Syndax Pharmaceuticals
SNDX
$1.20 B
0.000 M
USA icon
USA
Zymeworks Logo
Zymeworks
ZYME
$1.01 B
-0.000 M
Canada icon
Canada
Blueprint Medicines Logo
Blueprint Medicines
BPMC
$7.06 B
-0.000 M
USA icon
USA
Deciphera Pharmaceuticals Logo
Deciphera Pharmaceuticals
DCPH
$2.21 B
2.213 B
USA icon
USA
Iovance Biotherapeutics Logo
Iovance Biotherapeutics
IOVA
$1.83 B
-0.000 M
USA icon
USA
MacroGenics Logo
MacroGenics
MGNX
$0.19 B
-0.000 M
USA icon
USA
TG Therapeutics Logo
TG Therapeutics
TGTX
$4.54 B
0.000 M
USA icon
USA
Adaptimmune Therapeutics Logo
Adaptimmune Therapeutics
ADAP
$0.15 B
0.000 M
UK icon
UK
Allogene Therapeutics Logo
Allogene Therapeutics
ALLO
$0.40 B
0.000 M
USA icon
USA

About Viracta Therapeutics Inc.

Name
Viracta Therapeutics, Inc.
Headquarters
Cardiff,CA
symbol
VIRX
CURRENCY
USD
country
United States
fullTimeEmployees
40
exchange
NCM
firstTradeDateEpochUtc
2005/09/27
VIRX Market Cap Formula
Market Cap = VIRX Stock Price * VIRX Shares Outstanding
= $0.16 * 39.74 M
= $6.48 M
What is Market Cap?
Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.
Material